A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Traction Online
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and claims of rapid UK delivery. Sellers market the drug there before directing buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Experts Express Concerns
Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to users injecting products of unknown origin.
Some experts said the popularity for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.
Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, marketing, and consumer laws, risking penalties, prosecution or prison.
Platform Reaction and Content Removal
Based on TikTok, the platform has taken down violative content and prohibited related hashtags and search suggestions. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Trading Activities
Investigations also found communities with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, populated with images of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at home.
Within minutes of entering one community, a seller shared contact information, where the majority of transactions take place. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.
Product Information and Costs
Within these groups, posts show dark colored packages with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When questioned how long a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram said it actively moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they can’t verify. Even if the science behind this drug is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.
Her staff has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially significant medical dangers”.
